Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06426056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Name: Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial. — clinical trial record (NCT06426056)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorPeking University Third Hospital

Started2024-06

View on ClinicalTrials.gov ↗

Record status

This record was last updated May 23, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.

Peking University Third Hospital

219 trials monitored

See 3 trials at risk

Cervical Cancer

853 trials monitored

See 46 trials at risk

Based on the Phase I trial completed by the sponsor, the Phase II clinical trial aims to investigate the effectiveness and safety of image guidance volume-modulated arc radiation therapy concurrently with Nab-Paclitaxel plus Cisplatin for patients with locally advanced cervical cancer.

Trial Details

NCT Number	NCT06426056
Lead Sponsor	Peking University Third Hospital Collaborators: Jilin Provincial Tumor Hospital, Affiliated Hospital of Hebei University, Hebei Medical University Fourth Hospital
Conditions	Cervical Cancer
Enrollment	64 participants
Start Date	2024-06
Primary Completion	2025-09 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2024-05-23